JMP Securities Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $77
Portfolio Pulse from Benzinga Newsdesk
JMP Securities analyst Daniel Stauder maintains a Market Outperform rating on LeMaitre Vascular (NASDAQ:LMAT) and raises the price target from $72 to $77.
May 03, 2024 | 7:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
JMP Securities analyst Daniel Stauder maintains a Market Outperform rating on LeMaitre Vascular and raises the price target from $72 to $77.
The increase in price target by JMP Securities reflects a positive outlook on LeMaitre Vascular's future performance. This endorsement from a reputable analyst is likely to instill confidence in investors, potentially driving up the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100